WTAP acts as a mediator for the N6 methylation of the NLRP3 inflammatory component ASC, which in turn increases the stability of ASC RNAs and leads to the hyperactivation of inflammatory vesicles in the GCs of PCOS [32] (Fig. 2A). Here, WTAP is linked to polycystic ovary syndrome.